Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin, Radiation, Temozolomide, and Topotecan for Glioblastoma and Gliosarcoma
NCT01004874Phase 2Completed
- Sponsor
- Duke University
- Start
- Dec 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, topotecan in glioblastoma (GBM), Gliosarcoma (GS), sponsored by Duke University. Started Dec 2009; status: completed.
02
Drugs
bevacizumabtopotecan
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT01004874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004874.